#GETAID - Twitter Hashtag

almost 3 years ago · Copenhagen

#UEGW2023 #KonoS not superior to side-to-side anastomosis un terms of postoperative recurrence. #GETAID study comparing a prospective and a historical cohort.

IBDcanruti's tweet photo. #UEGW2023 #KonoS not superior to side-to-side anastomosis un terms of postoperative recurrence. #GETAID study comparing a prospective and a historical cohort. https://t.co/ccUVVnW6d1

1

7

3

0

564

GETAID @PGetaid

almost 3 years ago

The first #TRENCH patient has already been included in Limoges on 09/28 by Sophie Geyl ! SIV are underway in the other centers. #GETAID

PGetaid's tweet photo. The first #TRENCH patient has already been included in Limoges on 09/28 by Sophie Geyl ! SIV are underway in the other centers. #GETAID https://t.co/M4pAxRFGfQ

0

2

0

223

GETAID @PGetaid

about 3 years ago

ECCO 2023 conference in March : The Executive Committee and the entire #ICARE team are very proud to announce the freeze-in date of March 17, 2023. The #GETAID team would like to thank all the investigators at the centers for their hard work. We did it ! 💪

PGetaid's tweet photo. ECCO 2023 conference in March : The Executive Committee and the entire #ICARE team are very proud to announce the freeze-in date of March 17, 2023. The #GETAID team would like to thank all the investigators at the centers for their hard work. We did it ! 💪 https://t.co/QtVhsRZ7bA

0

16

3

0

3K

I-CARE @ICARE_ibd

about 3 years ago

ECCO 2023 conference in March : The Executive Committee and the entire #ICARE team are very proud to announce the freeze-in date of March 17, 2023. The #GETAID team would like to thank all the investigators at the centers for their hard work. We did it ! 💪

ICARE_ibd's tweet photo. ECCO 2023 conference in March : The Executive Committee and the entire #ICARE team are very proud to announce the freeze-in date of March 17, 2023. The #GETAID team would like to thank all the investigators at the centers for their hard work. We did it ! 💪 https://t.co/C0W6sFhjuW

0

4

1

0

870

IBDgermanstrias @IBDcanruti

almost 4 years ago

@PeyrinBiroulet @PGetaid Proud to collaborate in this #GETAID / #ECCO study involving many investigators over Europe and with a very active role of #IBD patients. Many, many robust resulta expected!

0

2

0

GETAID @PGetaid

over 4 years ago

#SPARE led by the marvelous #EdouardLouis with #GETAID presented at #ECCO2022

3

13

2

0

iris dotan @Iris_Dotan

over 4 years ago

Edoard Louis: SPARE at #ecco congress: #crohns patients in remission under combo #ifx and #thiopurines relapse more after stopping #ifx. Recapture with #ifx in majority. Another great #getaid study

Iris_Dotan's tweet photo. Edoard Louis: SPARE at #ecco congress: #crohns patients in remission under combo #ifx and #thiopurines relapse more after stopping #ifx. Recapture with #ifx in majority. Another great #getaid study https://t.co/iv5nhy26gl

0

23

4

1

0

afa-Crohn-RCH @afaCrohnRCH

over 4 years ago

Aujourd’hui, l’afa avec Chantal Dufresne, est présente au séminaire de recherche du #Getaid Remind en compagnie des plus grands experts MICI français, où l’on parle projets de recherche ! #Crohn #RCH #MICI

afaCrohnRCH's tweet photo. Aujourd’hui, l’afa avec Chantal Dufresne, est présente au séminaire de recherche du #Getaid Remind en compagnie des plus grands experts MICI français, où l’on parle projets de recherche ! #Crohn #RCH #MICI https://t.co/HoJ535vOai

0

11

2

0

JPGN @JPGNonline

almost 5 years ago

#GETAID and #ESPGHAN IBD Porto group performed European survey on digestive perianastomotic ulcerations (DPAU) - a rare complications occurring months/years after intestinal resection with anastomosis https://t.co/hHLGI4lVk4

JPGNonline's tweet photo. #GETAID and #ESPGHAN IBD Porto group performed European survey on digestive perianastomotic ulcerations (DPAU) - a rare complications occurring months/years after intestinal resection with anastomosis

https://t.co/hHLGI4lVk4 https://t.co/zmGx9XnHmQ

0

3

2

0

roypounder.apt @APandT

about 5 years ago

'Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study' #ustekinumab #UC #GETAID #IBD #gastroenterology Read at https://t.co/49BdLNqQ4k

APandT's tweet photo. 'Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study'
#ustekinumab #UC #GETAID #IBD #gastroenterology
Read at https://t.co/49BdLNqQ4k https://t.co/DjMahfepcd

0

10

5

0

Mathurin Fumery @MatFume

about 5 years ago

Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study #GETAID @PeyrinBiroulet @CHUAmiens https://t.co/FNunsE48ge

0

10

4

0

roypounder.apt @APandT

about 5 years ago

'Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis' #tofacitinib #colitis #IBD #GETAID Read at https://t.co/mAfvj4578A "tofacitinib avoided colectomy in a substantial proportion of patients"

$APandT's tweet photo. 'Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis' #tofacitinib #colitis #IBD #GETAID Read at https://t.co/mAfvj4578A "tofacitinib avoided colectomy in a substantial proportion of patients" https://t.co/DtWF7anq9F$

1

24

6

1

0

DigHacktion @DigHacktion

about 5 years ago

Découvrez le jury interdisciplinaire qui sera en charge de remettre les différents prix 🏆 à l'issue de #DigHacktion ! @Norgine @JanssenFRA @GileadSciences @GalapagosFrance @digilityx @afaCrohnRCH @L_AFDIAG #GETAID @FiliereFIMATHO #CFNG #CNPHGE

DigHacktion's tweet photo. Découvrez le jury interdisciplinaire qui sera en charge de remettre les différents prix 🏆 à l'issue de #DigHacktion !
@Norgine @JanssenFRA @GileadSciences @GalapagosFrance @digilityx @afaCrohnRCH @L_AFDIAG #GETAID @FiliereFIMATHO #CFNG #CNPHGE https://t.co/ijlNILqQo7

1

4

2

0

Jean-Guillaume Letarouilly @JGLetarouilly

over 5 years ago

N'hésitez pas à venir écouter les résultats finaux de l'étude #MISSIL (MICI de novo sous anti-IL17) soutenue par #CRI @Resopso et #GETAID. #SFR2020 😁

JGLetarouilly's tweet photo. N'hésitez pas à venir écouter les résultats finaux de l'étude #MISSIL (MICI de novo sous anti-IL17) soutenue par #CRI @Resopso et #GETAID. #SFR2020 😁 https://t.co/1KUSw4hkp0

1

9

2

0

Bram Verstockt @bverstockt

almost 6 years ago

@fgomollon The #Spare study as part of the #Biocycle project will hopefully answer some of those important questions @birdgroup_be #Getaid https://t.co/EFPIwuUpXk

0

1

0

Fernando Gomollón @fgomollon

almost 6 years ago

A. Meyer #GETAID study on pregnancy inn #IBD confirms activity of the disease is the only risk factor for bad outcomes. Huge study, old conclusion confirmed. @my_ueg @geteccu Great study, waiting for full data published!!!

fgomollon's tweet photo. A. Meyer #GETAID study on pregnancy inn #IBD confirms activity of the disease is the only risk factor for bad outcomes. Huge study, old conclusion confirmed. @my_ueg @geteccu Great study, waiting for full data published!!! https://t.co/NbfOVHdH86

1

22

5

2

0

IBD kliniek Bonheiden @ibd_kliniek

almost 6 years ago

Data about #ustekinumab dose intensification in #CD #IBD. Nice collaboration within #GETAID and happy to have collaborated! https://t.co/o5cae25DjX

0

3

2

0

Julien Kirchgesner @J_Kirchgesner

over 6 years ago

@fgomollon @my_ueg Thanks @fgomollon for the comment! As highlighted in the ST 1, we didn't only assess Herpesviridae, but also other SVI. We simply didn't identify any other SVI in our cohort than those reported, maybe related to the monocenter design. More collaboration needed! #GETECCU #GETAID

J_Kirchgesner's tweet photo. @fgomollon @my_ueg Thanks @fgomollon for the comment! As highlighted in the ST 1, we didn't only assess Herpesviridae, but also other SVI. We simply didn't identify any other SVI in our cohort than those reported, maybe related to the monocenter design. More collaboration needed! #GETECCU #GETAID https://t.co/WDORSCOzOw

2

0

IBDgermanstrias @IBDcanruti

over 6 years ago

Data from the #EPIMAD registry in pediatric #IBD from #GETAID reproduces the data of #eneida by @geteccu (CIRBIO study) in adults. Biologicals pushed to earlier introduction of IMS and reduced surgery in #CD butlla notable in #UC. #ECCC2020

0

3

1

0

Fernando Gomollón @fgomollon

over 6 years ago

@DCharabaty @VicentHernande9 @ryanungaro @juliomayol @MondayNightIBD @MRegueiroMD @geteccu In these times is really difficult to be aware of all relevant literature. As a participant in the three last editions of #Crohn #ECCO guidelines I do testify our task increasingly difficult. @geteccu and #Getaid doing great efforts for responses to clinically relevant questions

1

2

0

Top Tweets for #GETAID

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users